Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes

Overview of attention for article published in Clinical Ophthalmology, March 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study

Article in International Ophthalmology (July 2023)

The impact of retinal fluid tolerance on the outcomes of neovascular age-related macular degeneration treated using aflibercept: A real-world study

Article in PLOS ONE (July 2022)

Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Article in Indian Journal of Ophthalmology (May 2022)